VMPL
Bengaluru (Karnataka) [India], June 28: The number of cataract patients in India has been steadily increasing, driven by the country's aging population and the high prevalence of risk factors such as diabetes, hypertension and prolonged exposure to ultraviolet (UV) rays. radiation. According to recent studies, more than 12 million people in India are affected by cataracts and this number is expected to increase significantly in the coming years. The increasing prevalence of cataracts is not only a major public health problem but also poses a significant economic burden due to costs associated with treatment and loss of productivity.
This increase in cataract cases underscores the urgent need for comprehensive eye care services and public health interventions. Despite advances in medical technology and surgical techniques, access to quality cataract treatment remains unequal, especially in rural and underserved areas. Efforts to address this challenge include increasing public awareness of cataracts, improving the availability of surgical and diagnostic facilities, and training more ophthalmologists to meet the growing demand for eye care services. Addressing these issues is critical to preventing visual impairment and ensuring a better quality of life for millions of people across India.
ZEISS Group in India is proud to be at the forefront of the cataract treatment revolution with its innovative ZEISS Premium Cataract Workflow during the ongoing Cataract Awareness Month.
ZEISS Premium Cataract Workflow is an integrated solution designed to optimize every stage of the cataract surgery process. From preoperative diagnosis to postoperative care, ZEISS offers a comprehensive set of tools and technologies that improve the accuracy, safety and efficiency of cataract surgeries.
Key components of the ZEISS Premium Cataract Workflow include:
Preoperative Diagnosis: Accurate diagnosis and planning are critical to successful cataract surgery. ZEISS offers advanced diagnostic devices, such as the ZEISS IOLMaster® and ZEISS CIRRUS® HD-OCT, that provide detailed measurements and images of the eye. These tools help ophthalmologists determine the appropriate intraocular lens (IOL) and create a personalized treatment plan.
Surgical planning and guidance: ZEISS CALLISTO eye® and ZEISS FORUM® provide digital planning and integration capabilities, allowing surgeons to visualize and plan the procedure with high precision. Digital markers and overlays help achieve precise IOL positioning and astigmatism management, ensuring optimal surgical results.
Intraoperative visualization and support: The ZEISS ARTEVO 800 and ZEISS OPMI LUMERA® surgical microscopes offer exceptional clarity and depth perception, allowing surgeons to perform delicate procedures with confidence. Additionally, the ZEISS CALLISTO eye® system provides real-time data and visual guidance during surgery, improving precision and reducing the risk of complications.
Advanced Intraocular Lenses (IOLs): ZEISS offers a range of premium IOLs, including ZEISS AT LISA tri, ZEISS AT LARA® and ZEISS AT TORBI®, designed to meet diverse patient needs. These lenses provide excellent visual results, including better near, intermediate, and distance vision, and are available in toric versions to correct astigmatism.
Post-operative care: ZEISS FORUM® and the ZEISS EQ Mobile® app facilitate seamless post-operative monitoring and data management. These tools allow ophthalmologists to track patient progress, manage results, and ensure any issues are resolved quickly.
The ZEISS Group remains committed to raising awareness about the impact of cataracts and the importance of early diagnosis and advanced treatment options. It is imperative that stakeholders, including healthcare providers, policymakers, and communities, collaborate to address this growing health problem. By leveraging innovative solutions like ZEISS Premium Cataract Workflow and prioritizing comprehensive eye care, we can significantly reduce the burden of cataracts, improve the quality of life for those affected, and ensure a brighter, clearer future for millions of people across the country. .
For any additional media inquiries, please contact:
Kajal Kamal | +91 9582870715 | [email protected]
Bengaluru (Karnataka) [India], June 28: The number of cataract patients in India has been steadily increasing, driven by the country's aging population and the high prevalence of risk factors such as diabetes, hypertension and prolonged exposure to ultraviolet (UV) rays. radiation. According to recent studies, more than 12 million people in India are affected by cataracts and this number is expected to increase significantly in the coming years. The increasing prevalence of cataracts is not only a major public health problem but also poses a significant economic burden due to costs associated with treatment and loss of productivity.
This increase in cataract cases underscores the urgent need for comprehensive eye care services and public health interventions. Despite advances in medical technology and surgical techniques, access to quality cataract treatment remains unequal, especially in rural and underserved areas. Efforts to address this challenge include increasing public awareness of cataracts, improving the availability of surgical and diagnostic facilities, and training more ophthalmologists to meet the growing demand for eye care services. Addressing these issues is critical to preventing visual impairment and ensuring a better quality of life for millions of people across India.
ZEISS Group in India is proud to be at the forefront of the cataract treatment revolution with its innovative ZEISS Premium Cataract Workflow during the ongoing Cataract Awareness Month.
ZEISS Premium Cataract Workflow is an integrated solution designed to optimize every stage of the cataract surgery process. From preoperative diagnosis to postoperative care, ZEISS offers a comprehensive set of tools and technologies that improve the accuracy, safety and efficiency of cataract surgeries.
Key components of the ZEISS Premium Cataract Workflow include:
Preoperative Diagnosis: Accurate diagnosis and planning are critical to successful cataract surgery. ZEISS offers advanced diagnostic devices, such as the ZEISS IOLMaster® and ZEISS CIRRUS® HD-OCT, that provide detailed measurements and images of the eye. These tools help ophthalmologists determine the appropriate intraocular lens (IOL) and create a personalized treatment plan.
Surgical planning and guidance: ZEISS CALLISTO eye® and ZEISS FORUM® provide digital planning and integration capabilities, allowing surgeons to visualize and plan the procedure with high precision. Digital markers and overlays help achieve precise IOL positioning and astigmatism management, ensuring optimal surgical results.
Intraoperative visualization and support: The ZEISS ARTEVO 800 and ZEISS OPMI LUMERA® surgical microscopes offer exceptional clarity and depth perception, allowing surgeons to perform delicate procedures with confidence. Additionally, the ZEISS CALLISTO eye® system provides real-time data and visual guidance during surgery, improving precision and reducing the risk of complications.
Advanced Intraocular Lenses (IOLs): ZEISS offers a range of premium IOLs, including ZEISS AT LISA tri, ZEISS AT LARA® and ZEISS AT TORBI®, designed to meet diverse patient needs. These lenses provide excellent visual results, including better near, intermediate, and distance vision, and are available in toric versions to correct astigmatism.
Post-operative care: ZEISS FORUM® and the ZEISS EQ Mobile® app facilitate seamless post-operative monitoring and data management. These tools allow ophthalmologists to track patient progress, manage results, and ensure any issues are resolved quickly.
The ZEISS Group remains committed to raising awareness about the impact of cataracts and the importance of early diagnosis and advanced treatment options. It is imperative that stakeholders, including healthcare providers, policymakers, and communities, collaborate to address this growing health problem. By leveraging innovative solutions like ZEISS Premium Cataract Workflow and prioritizing comprehensive eye care, we can significantly reduce the burden of cataracts, improve the quality of life for those affected, and ensure a brighter, clearer future for millions of people across the country. .
For any additional media inquiries, please contact:
Kajal Kamal | +91 9582870715 | [email protected]
